<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; Barcelona</title>
	<atom:link href="http://pr.gaeatimes.com/t/barcelona/feed/" rel="self" type="application/rss+xml" />
	<link>http://pr.gaeatimes.com</link>
	<description></description>
	<pubDate>Wed, 14 Dec 2011 08:03:16 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen</title>
		<link>http://pr.gaeatimes.com/kymos-a-catalan-company-signs-a-collaboration-agreement-with-the-pharmaceutical-group-ipsen-54824/</link>
		<comments>http://pr.gaeatimes.com/kymos-a-catalan-company-signs-a-collaboration-agreement-with-the-pharmaceutical-group-ipsen-54824/#comments</comments>
		<pubDate>Wed, 14 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Kymos Pharma Services</dc:creator>
		
		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[December 14]]></category>

		<category><![CDATA[Kymos Pharma Services]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/kymos-a-catalan-company-signs-a-collaboration-agreement-with-the-pharmaceutical-group-ipsen-54824/</guid>
		<description><![CDATA[BARCELONA, Spain, December 14, 2011  -

The Contract Research Organization Kymos Pharma Services -specialised in analysis for the pharmaceutical, fine chemicals, biotechnological, veterinary, cosmetic and nutraceuticals sectors- has signed an agreement with the French multinational group Ipsen to take in a team of eight scientists from Ipsen R&#38;D Centre in Sant Feliu de Llobregat (Barcelona).
For .... <a href="http://pr.gaeatimes.com/kymos-a-catalan-company-signs-a-collaboration-agreement-with-the-pharmaceutical-group-ipsen-54824/">Source article &nbsp;: Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/kymos-a-catalan-company-signs-a-collaboration-agreement-with-the-pharmaceutical-group-ipsen-54824/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Actelion Pharmaceuticals Takes to the Cloud with Global Deployment of Veeva CRM and iRep</title>
		<link>http://pr.gaeatimes.com/actelion-pharmaceuticals-takes-to-the-cloud-with-global-deployment-of-veeva-crm-and-irep-54135/</link>
		<comments>http://pr.gaeatimes.com/actelion-pharmaceuticals-takes-to-the-cloud-with-global-deployment-of-veeva-crm-and-irep-54135/#comments</comments>
		<pubDate>Thu, 01 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Veeva Systems</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Workforce Management / Human Resources]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[December 1]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Veeva Systems]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/actelion-pharmaceuticals-takes-to-the-cloud-with-global-deployment-of-veeva-crm-and-irep-54135/</guid>
		<description><![CDATA[BARCELONA, Spain, December 1, 2011  -

Multiple client/server SFA systems worldwide replaced by single cloud-based CRM solution
Before selecting cloud-based Veeva CRM for 500+ users worldwide, Actelion Ltd. had been operating 10 different client/server salesforce automation (SFA) systems - all from various vendors - throughout its operations around the world. This technology labyrinth was increasingly expensive  [..] <a href="http://pr.gaeatimes.com/actelion-pharmaceuticals-takes-to-the-cloud-with-global-deployment-of-veeva-crm-and-irep-54135/">Read the original article: here</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/actelion-pharmaceuticals-takes-to-the-cloud-with-global-deployment-of-veeva-crm-and-irep-54135/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Barcelona Lights up in Red in the Fight Against AIDS</title>
		<link>http://pr.gaeatimes.com/barcelona-lights-up-in-red-in-the-fight-against-aids-54185/</link>
		<comments>http://pr.gaeatimes.com/barcelona-lights-up-in-red-in-the-fight-against-aids-54185/#comments</comments>
		<pubDate>Thu, 01 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Fundacio Lluita Sida</dc:creator>
		
		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Travel]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[December 1]]></category>

		<category><![CDATA[Fundacio Lluita Sida]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/barcelona-lights-up-in-red-in-the-fight-against-aids-54185/</guid>
		<description><![CDATA[BARCELONA, Spain, December 1, 2011  -


Many buildings such as La Sagrada Familia and la Pedrera will light up in red coinciding with World AIDS Day for the second consecutive year


The initiative is expected to be repeated in Barcelona each year to become an international reference in the fight against AIDS

Coinciding with World AIDSDay, a ... <a href="http://pr.gaeatimes.com/barcelona-lights-up-in-red-in-the-fight-against-aids-54185/" title="Barcelona Lights up in Red in the Fight Against AIDS">Read more &raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/barcelona-lights-up-in-red-in-the-fight-against-aids-54185/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Monlau Competición, School of Marc Marquez, has Launched a Motorsport Engineering Course in the Areas of Motorcycle and Car Racing</title>
		<link>http://pr.gaeatimes.com/monlau-competicion-school-of-marc-marquez-has-launched-a-motorsport-engineering-course-in-the-areas-of-motorcycle-and-car-racing-53568/</link>
		<comments>http://pr.gaeatimes.com/monlau-competicion-school-of-marc-marquez-has-launched-a-motorsport-engineering-course-in-the-areas-of-motorcycle-and-car-racing-53568/#comments</comments>
		<pubDate>Thu, 17 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Monlau Competicion</dc:creator>
		
		<category><![CDATA[Auto]]></category>

		<category><![CDATA[Auto and Transportation]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Education]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Transportation / Trucking / Railroad]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Monlau Competicion]]></category>

		<category><![CDATA[November 17]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/monlau-competicion-school-of-marc-marquez-has-launched-a-motorsport-engineering-course-in-the-areas-of-motorcycle-and-car-racing-53568/</guid>
		<description><![CDATA[BARCELONA, November 17, 2011  -


RACE MOTORCYCLE ENGINEERING COURSE Full time 72 hours
RACE CAR ENGINEERING COURSE Full time 72 hours


This Intensive course will run from January 16 to February 2, 2012
Monlau Competición, the school of reference in Spain, is the Spanish pioneer as far as racing mechanic and engineer training is concerned.
To view the Multimedia News Release, please click:
multivu.prnewswire.com/mnr/prne/monlaucompeticion/52781/  
Monlau Competición is lead by former 125cc world champion Emilio Alzamora, who was born in 1973 and has over 25 years of experience in the field of .... Source &nbsp;: <a href="http://pr.gaeatimes.com/monlau-competicion-school-of-marc-marquez-has-launched-a-motorsport-engineering-course-in-the-areas-of-motorcycle-and-car-racing-53568/">Monlau Competición, School of Marc Marquez, has Launched a Motorsport Engineering Course in the Areas of Motorcycle and Car Racing</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/monlau-competicion-school-of-marc-marquez-has-launched-a-motorsport-engineering-course-in-the-areas-of-motorcycle-and-car-racing-53568/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Almirall Starts Phase III for Aclidinium and Formoterol in COPD</title>
		<link>http://pr.gaeatimes.com/almirall-starts-phase-iii-for-aclidinium-and-formoterol-in-copd-53488/</link>
		<comments>http://pr.gaeatimes.com/almirall-starts-phase-iii-for-aclidinium-and-formoterol-in-copd-53488/#comments</comments>
		<pubDate>Wed, 16 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Almirall S.a.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Almirall S.a.]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[November 16]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/almirall-starts-phase-iii-for-aclidinium-and-formoterol-in-copd-53488/</guid>
		<description><![CDATA[BARCELONA, November 16, 2011  -



Almirall&#8217;s respiratory franchise continues to expand in COPD

Clinical trials of the double bronchodilator combination have commenced to satisfy European and North American regulatory requirements

Almirall, S.A. (ALM.MC) today announced that, together with its US partner Forest, initiated a Phase III clinical programme of the fixed dose combination (FDC) of aclidinium bromide ... Original article on  : <a href="http://pr.gaeatimes.com/almirall-starts-phase-iii-for-aclidinium-and-formoterol-in-copd-53488/">Almirall Starts Phase III for Aclidinium and Formoterol in COPD</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/almirall-starts-phase-iii-for-aclidinium-and-formoterol-in-copd-53488/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Zinio&#8217;s Global Magazine Marketplace Now Available on Virtually Every Tablet and Smartphone Around the World</title>
		<link>http://pr.gaeatimes.com/zinios-global-magazine-marketplace-now-available-on-virtually-every-tablet-and-smartphone-around-the-world-53399/</link>
		<comments>http://pr.gaeatimes.com/zinios-global-magazine-marketplace-now-available-on-virtually-every-tablet-and-smartphone-around-the-world-53399/#comments</comments>
		<pubDate>Tue, 15 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Zinio</dc:creator>
		
		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Magazines]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[Mobile Entertainment]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Wireless Communications]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[November 15]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Zinio]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/zinios-global-magazine-marketplace-now-available-on-virtually-every-tablet-and-smartphone-around-the-world-53399/</guid>
		<description><![CDATA[BARCELONA, Spain, November 15, 2011  -


World&#8217;s Largest Newsstand Gives 15 GBP Shopping Perk To All New Registrants Worldwide Through March 2012 Across Selection of 5,000+ Magazines
 
Zinio, the world&#8217;s largest and most popular magazine marketplace, is now available on more tablet devices than any other newsstand or magazine reader, including on the iPad, ASUS Transformer, Acer Iconia, ... Read more : <a href="http://pr.gaeatimes.com/zinios-global-magazine-marketplace-now-available-on-virtually-every-tablet-and-smartphone-around-the-world-53399/">Zinio&#8217;s Global Magazine Marketplace Now Available on Virtually Every Tablet and Smartphone Around the World</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/zinios-global-magazine-marketplace-now-available-on-virtually-every-tablet-and-smartphone-around-the-world-53399/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Human Genome Sciences Europe Moves to the Cloud With Veeva CRM to Support New Lupus Treatment</title>
		<link>http://pr.gaeatimes.com/human-genome-sciences-europe-moves-to-the-cloud-with-veeva-crm-to-support-new-lupus-treatment-52736/</link>
		<comments>http://pr.gaeatimes.com/human-genome-sciences-europe-moves-to-the-cloud-with-veeva-crm-to-support-new-lupus-treatment-52736/#comments</comments>
		<pubDate>Wed, 02 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Veeva Systems</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[November 2]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Veeva Systems]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/human-genome-sciences-europe-moves-to-the-cloud-with-veeva-crm-to-support-new-lupus-treatment-52736/</guid>
		<description><![CDATA[BARCELONA, Spain, November 2, 2011  -

In preparation for its European launch of Benlysta, the first FDA approved Lupus drug in 50 years, Human Genome Sciences (HGS) needed a customer relationship management (CRM) system to arm its newly formed European commercial sales team. The company had a long list of selection criteria including ease of ... <a href="http://pr.gaeatimes.com/human-genome-sciences-europe-moves-to-the-cloud-with-veeva-crm-to-support-new-lupus-treatment-52736/">Original source on Gaea Times at  : Human Genome Sciences Europe Moves to the Cloud With Veeva CRM to Support New Lupus Treatment</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/human-genome-sciences-europe-moves-to-the-cloud-with-veeva-crm-to-support-new-lupus-treatment-52736/feed/</wfw:commentRss>
		</item>
		<item>
		<title>eDreams Launches New Facebook Travel Game</title>
		<link>http://pr.gaeatimes.com/edreams-launches-new-facebook-travel-game-52690/</link>
		<comments>http://pr.gaeatimes.com/edreams-launches-new-facebook-travel-game-52690/#comments</comments>
		<pubDate>Tue, 01 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Edreams</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Social Media]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Travel]]></category>

		<category><![CDATA[Web]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Edreams]]></category>

		<category><![CDATA[Facebook]]></category>

		<category><![CDATA[November 1]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Ukraine]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/edreams-launches-new-facebook-travel-game-52690/</guid>
		<description><![CDATA[BARCELONA, Spain, November 1, 2011  -

Online travel agency eDreams   has launched an innovative travel game on their Facebook Page. Participants are invited to add kilos to their rivals&#8216; suitcases and keep their own luggage as light as they can, in a race for a fun prize: a trip for 4 to Madrid or Kiev.

Today eDreams launched a .... <a href="http://pr.gaeatimes.com/edreams-launches-new-facebook-travel-game-52690/">Read the original article &nbsp;: eDreams Launches New Facebook Travel Game</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/edreams-launches-new-facebook-travel-game-52690/feed/</wfw:commentRss>
		</item>
		<item>
		<title>NComputing and Citrix Herald New Era of VDI</title>
		<link>http://pr.gaeatimes.com/ncomputing-and-citrix-herald-new-era-of-vdi-52422/</link>
		<comments>http://pr.gaeatimes.com/ncomputing-and-citrix-herald-new-era-of-vdi-52422/#comments</comments>
		<pubDate>Wed, 26 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Ncomputing</dc:creator>
		
		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[NComputing]]></category>

		<category><![CDATA[October 26]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/ncomputing-and-citrix-herald-new-era-of-vdi-52422/</guid>
		<description><![CDATA[BARCELONA, Spain, October 26, 2011  -



Integration of Citrix HDX&#8482; and NComputing Numo&#8482; SoC Technology Will Deliver New Virtual Client Reference Design
Revolutionizes price/performance, power consumption and form factor paradigm

NComputing today announced a strategic collaboration with Citrix that will advance virtual client technology innovation as a result of a new Citrix HDX Ready System-on-Chip (SoC) reference .... <a href="http://pr.gaeatimes.com/ncomputing-and-citrix-herald-new-era-of-vdi-52422/">Source article on Gaea Times at  &nbsp;: NComputing and Citrix Herald New Era of VDI</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/ncomputing-and-citrix-herald-new-era-of-vdi-52422/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Stallergenes Moves to the Cloud With Veeva CRM</title>
		<link>http://pr.gaeatimes.com/stallergenes-moves-to-the-cloud-with-veeva-crm-51647/</link>
		<comments>http://pr.gaeatimes.com/stallergenes-moves-to-the-cloud-with-veeva-crm-51647/#comments</comments>
		<pubDate>Tue, 11 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Veeva Systems</dc:creator>
		
		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[October 11]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Veeva Systems]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/stallergenes-moves-to-the-cloud-with-veeva-crm-51647/</guid>
		<description><![CDATA[BARCELONA, Spain, October 11, 2011  -

Leading Specialty Pharmaceutical Company Consolidates Four On-Premise CRM Systems into One
Stallergenes, the world leader in sublingual immunotherapy, has selected Veeva CRM to replace its existing conventional on-premise systems to support its worldwide sales force. Veeva CRM is today&#8217;s #1 selling cloud-based CRM solution for the global pharmaceutical and biotech ... Read this article on Gaea Times at  : <a href="http://pr.gaeatimes.com/stallergenes-moves-to-the-cloud-with-veeva-crm-51647/">Stallergenes Moves to the Cloud With Veeva CRM</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/stallergenes-moves-to-the-cloud-with-veeva-crm-51647/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Almirall Announces Regulatory Filing of linaclotide for the Treatment of Irritable Bowel Syndrome With Constipation in Europe</title>
		<link>http://pr.gaeatimes.com/almirall-announces-regulatory-filing-of-linaclotide-for-the-treatment-of-irritable-bowel-syndrome-with-constipation-in-europe-51128/</link>
		<comments>http://pr.gaeatimes.com/almirall-announces-regulatory-filing-of-linaclotide-for-the-treatment-of-irritable-bowel-syndrome-with-constipation-in-europe-51128/#comments</comments>
		<pubDate>Thu, 29 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Almirall S.a.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Almirall S.a.]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[September 29]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/almirall-announces-regulatory-filing-of-linaclotide-for-the-treatment-of-irritable-bowel-syndrome-with-constipation-in-europe-51128/</guid>
		<description><![CDATA[BARCELONA, Spain, September 29, 2011  -


- Linaclotide has demonstrated statistically significant improvement in abdominal pain/discomfort and global relief of IBS-C symptoms in Phase III clinical trials [1,2]
- IBS-C is a debilitating disease associated with reduced quality of life and considerable socio-economic and psychological consequences [3,4]
Almirall, S.A. (ALM.MC) announced today that it has submitted a ... Original article on  : <a href="http://pr.gaeatimes.com/almirall-announces-regulatory-filing-of-linaclotide-for-the-treatment-of-irritable-bowel-syndrome-with-constipation-in-europe-51128/">Almirall Announces Regulatory Filing of linaclotide for the Treatment of Irritable Bowel Syndrome With Constipation in Europe</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/almirall-announces-regulatory-filing-of-linaclotide-for-the-treatment-of-irritable-bowel-syndrome-with-constipation-in-europe-51128/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Pharco Pharma NV/SA Leverages Advantages of Cloud Computing With the Implementation of Veeva CRM</title>
		<link>http://pr.gaeatimes.com/pharco-pharma-nvsa-leverages-advantages-of-cloud-computing-with-the-implementation-of-veeva-crm-50313/</link>
		<comments>http://pr.gaeatimes.com/pharco-pharma-nvsa-leverages-advantages-of-cloud-computing-with-the-implementation-of-veeva-crm-50313/#comments</comments>
		<pubDate>Wed, 14 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Veeva Systems</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[September 14]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Veeva Systems]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/pharco-pharma-nvsa-leverages-advantages-of-cloud-computing-with-the-implementation-of-veeva-crm-50313/</guid>
		<description><![CDATA[BARCELONA, September 14, 2011  -

Pharco Pharma NV/SA, a rapidly growing pharmaceutical company specialising in prescribed, OTC medications (OTX) and food supplements, has implemented Veeva CRM to support its salesforce in Belgium. Pharco required an affordable and intuitive Customer Relationship Management (CRM) application that was both pharma-specific and easily adaptable. The company turned to Veeva ... Read the original article on Gaea Times at  : <a href="http://pr.gaeatimes.com/pharco-pharma-nvsa-leverages-advantages-of-cloud-computing-with-the-implementation-of-veeva-crm-50313/">Pharco Pharma NV/SA Leverages Advantages of Cloud Computing With the Implementation of Veeva CRM</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/pharco-pharma-nvsa-leverages-advantages-of-cloud-computing-with-the-implementation-of-veeva-crm-50313/feed/</wfw:commentRss>
		</item>
		<item>
		<title>eDreams Breaks Travel Stereotypes with Launch of New Blog Design and Video</title>
		<link>http://pr.gaeatimes.com/edreams-breaks-travel-stereotypes-with-launch-of-new-blog-design-and-video-50332/</link>
		<comments>http://pr.gaeatimes.com/edreams-breaks-travel-stereotypes-with-launch-of-new-blog-design-and-video-50332/#comments</comments>
		<pubDate>Wed, 14 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Edreams</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Travel]]></category>

		<category><![CDATA[Web]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Edreams]]></category>

		<category><![CDATA[Facebook]]></category>

		<category><![CDATA[September 14]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/edreams-breaks-travel-stereotypes-with-launch-of-new-blog-design-and-video-50332/</guid>
		<description><![CDATA[BARCELONA, September 14, 2011  -

In a bid to break stereotypical views of travel in general, as well as specific destinations, eDreams has just launched its brand new blog design to coincide with the release of their surprising short film.
Today eDreams launched their new travel blog design, along with their colourful short film entitled Barcelona ... Read more : <a href="http://pr.gaeatimes.com/edreams-breaks-travel-stereotypes-with-launch-of-new-blog-design-and-video-50332/">eDreams Breaks Travel Stereotypes with Launch of New Blog Design and Video</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/edreams-breaks-travel-stereotypes-with-launch-of-new-blog-design-and-video-50332/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Mediterranean and Balearic Islands Still Top Choices for European Summer Travels</title>
		<link>http://pr.gaeatimes.com/mediterranean-and-balearic-islands-still-top-choices-for-european-summer-travels-50019/</link>
		<comments>http://pr.gaeatimes.com/mediterranean-and-balearic-islands-still-top-choices-for-european-summer-travels-50019/#comments</comments>
		<pubDate>Thu, 08 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Edreams</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Hotels and Resorts]]></category>

		<category><![CDATA[Leisure]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Travel]]></category>

		<category><![CDATA[Web]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Edreams]]></category>

		<category><![CDATA[September 8]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/mediterranean-and-balearic-islands-still-top-choices-for-european-summer-travels-50019/</guid>
		<description><![CDATA[BARCELONA, Spain, September 8, 2011  -

With the summer travel season winding down, eDreams releases infographic about European travel trends and top destinations for the summer holidays.

The online travel agency eDreams has conducted a study on the most popular summer holiday destinations and published an infographic with the most interesting data found.
To view the Multimedia .... <a href="http://pr.gaeatimes.com/mediterranean-and-balearic-islands-still-top-choices-for-european-summer-travels-50019/" title="Mediterranean and Balearic Islands Still Top Choices for European Summer Travels">Source &nbsp;: Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/mediterranean-and-balearic-islands-still-top-choices-for-european-summer-travels-50019/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Selects Veeva CRM for European-Wide Deployments</title>
		<link>http://pr.gaeatimes.com/astellas-selects-veeva-crm-for-european-wide-deployments-49924/</link>
		<comments>http://pr.gaeatimes.com/astellas-selects-veeva-crm-for-european-wide-deployments-49924/#comments</comments>
		<pubDate>Wed, 07 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Veeva Systems</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[September 7]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Veeva Systems]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/astellas-selects-veeva-crm-for-european-wide-deployments-49924/</guid>
		<description><![CDATA[BARCELONA, Spain, September 7, 2011  -


Veeva Celebrates 100th Customer Globally
Veeva Systems announced today that Astellas Pharma Europe Ltd., European subsidiary of Astellas Pharma Inc., has chosen Veeva CRM as its European CRM standard for 2,000 users in more than 20 countries. Looking for a pioneering CRM solution to support its new and developing commercial ... <a href="http://pr.gaeatimes.com/astellas-selects-veeva-crm-for-european-wide-deployments-49924/">Original source on Gaea Times at  : Astellas Selects Veeva CRM for European-Wide Deployments</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-selects-veeva-crm-for-european-wide-deployments-49924/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Ron Arad Will Award the Winner of Jump the Gap at Roca London Gallery</title>
		<link>http://pr.gaeatimes.com/ron-arad-will-award-the-winner-of-jump-the-gap-at-roca-london-gallery-48475/</link>
		<comments>http://pr.gaeatimes.com/ron-arad-will-award-the-winner-of-jump-the-gap-at-roca-london-gallery-48475/#comments</comments>
		<pubDate>Thu, 28 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Roca</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Construction / Building]]></category>

		<category><![CDATA[Consumer Products]]></category>

		<category><![CDATA[Household Products]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Textiles]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[July 28]]></category>

		<category><![CDATA[Roca]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/ron-arad-will-award-the-winner-of-jump-the-gap-at-roca-london-gallery-48475/</guid>
		<description><![CDATA[BARCELONA, July 28, 2011  -


Ron Arad, chairman of the judging panel, will award the prize to the winner in early November in London, at the new Roca London Gallery designed by Zaha Hadid



The 4th edition of the competition has set a participation record, receiving 3,004 entries from 92 countries


The jury of the 4th Roca International Design Contest Jump the Gap has chosen ... Read more : <a href="http://pr.gaeatimes.com/ron-arad-will-award-the-winner-of-jump-the-gap-at-roca-london-gallery-48475/">Ron Arad Will Award the Winner of Jump the Gap at Roca London Gallery</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/ron-arad-will-award-the-winner-of-jump-the-gap-at-roca-london-gallery-48475/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Aclidinium Bromide Submitted for Registration in Europe</title>
		<link>http://pr.gaeatimes.com/aclidinium-bromide-submitted-for-registration-in-europe-48421/</link>
		<comments>http://pr.gaeatimes.com/aclidinium-bromide-submitted-for-registration-in-europe-48421/#comments</comments>
		<pubDate>Wed, 27 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Almirall S.a.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Almirall S.a.]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[July 27]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/aclidinium-bromide-submitted-for-registration-in-europe-48421/</guid>
		<description><![CDATA[BARCELONA, July 27, 2011  -
?


In clinical trials, aclidinium has shown 24-hour symptoms control, full bronchodilatory effect from the first day and tolerability similar to placebo
Further details on the Phase III programme will be presented at the ERS congress in September


Almirall, S.A. (ALM.MC) announced today the submission of a  Marketing Authorisation Application (MAA) to the European Medicines .... <a href="http://pr.gaeatimes.com/aclidinium-bromide-submitted-for-registration-in-europe-48421/">Source &nbsp;: Aclidinium Bromide Submitted for Registration in Europe</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/aclidinium-bromide-submitted-for-registration-in-europe-48421/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom</title>
		<link>http://pr.gaeatimes.com/daiichi-sankyo-selects-veeva-crm-to-support-customer-engagement-initiatives-in-the-united-kingdom-48365/</link>
		<comments>http://pr.gaeatimes.com/daiichi-sankyo-selects-veeva-crm-to-support-customer-engagement-initiatives-in-the-united-kingdom-48365/#comments</comments>
		<pubDate>Tue, 26 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Veeva Systems And Daiichi Sankyo</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Europe]]></category>

		<category><![CDATA[July 26]]></category>

		<category><![CDATA[Spain And Gerrards Cross]]></category>

		<category><![CDATA[Veeva Systems And Daiichi Sankyo]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/daiichi-sankyo-selects-veeva-crm-to-support-customer-engagement-initiatives-in-the-united-kingdom-48365/</guid>
		<description><![CDATA[BARCELONA, Spain and GERRARDS CROSS, England, July 26, 2011  -


Veeva Systems announced today that Daiichi Sankyo, one of the
world&#8217;s top 20 pharmaceutical companies, is replacing its legacy,
on-premise Customer Relationship Management (CRM) system with Veeva
CRM in the UK. Daiichi Sankyo will deploy Veeva CRM to all of its
commercial teams in the UK including integrated healthcare,
specialty .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/daiichi-sankyo-selects-veeva-crm-to-support-customer-engagement-initiatives-in-the-united-kingdom-48365/">here</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/daiichi-sankyo-selects-veeva-crm-to-support-customer-engagement-initiatives-in-the-united-kingdom-48365/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects</title>
		<link>http://pr.gaeatimes.com/start-of-in-patient-clinical-trials-with-nt-ko-003-the-first-neuroprotective-drug-for-multiple-sclerosis-without-immunosuppressive-effects-48124/</link>
		<comments>http://pr.gaeatimes.com/start-of-in-patient-clinical-trials-with-nt-ko-003-the-first-neuroprotective-drug-for-multiple-sclerosis-without-immunosuppressive-effects-48124/#comments</comments>
		<pubDate>Tue, 19 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Advancell</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Advancell]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[July 19]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/start-of-in-patient-clinical-trials-with-nt-ko-003-the-first-neuroprotective-drug-for-multiple-sclerosis-without-immunosuppressive-effects-48124/</guid>
		<description><![CDATA[BARCELONA, July 19, 2011  -


&#8226; NT-KO-003, developed by Advancell and Neurotec Pharma, is the
first MS drug with neuroprotective effects that does not cause
immunosuppression.
&#8226; This treatment is one of the first
to be administered orally, whereas the few treatments available in
Spain require parenteral administration (intravenous or
subcutaneous) and have significant side effects.
&#8226; NeuroAdvan, the Phase IIa clinical ... Original article on  : <a href="http://pr.gaeatimes.com/start-of-in-patient-clinical-trials-with-nt-ko-003-the-first-neuroprotective-drug-for-multiple-sclerosis-without-immunosuppressive-effects-48124/">Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/start-of-in-patient-clinical-trials-with-nt-ko-003-the-first-neuroprotective-drug-for-multiple-sclerosis-without-immunosuppressive-effects-48124/feed/</wfw:commentRss>
		</item>
		<item>
		<title>SuperGay &amp; the Attack of his Ex-Girlfriends Videogame Comes Out Available for Apple Platforms</title>
		<link>http://pr.gaeatimes.com/supergay-the-attack-of-his-ex-girlfriends-videogame-comes-out-available-for-apple-platforms-47250/</link>
		<comments>http://pr.gaeatimes.com/supergay-the-attack-of-his-ex-girlfriends-videogame-comes-out-available-for-apple-platforms-47250/#comments</comments>
		<pubDate>Tue, 28 Jun 2011 05:00:00 +0000</pubDate>
		<dc:creator>Super Gay Games</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Facebook]]></category>

		<category><![CDATA[June 28]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Super Gay Games]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/supergay-the-attack-of-his-ex-girlfriends-videogame-comes-out-available-for-apple-platforms-47250/</guid>
		<description><![CDATA[BARCELONA, June 28, 2011  -

 
 
World&#8217;s First Launch of a Gay Superhero Videogame

Klicrainbow comes out into the market with &#8220;SuperGay &#38; the
Attack of his ExGirlfiends&#8221;, the first videogame about a gay
superhero, available for Apple platforms: iPhone, iPad and iPod
Touch.
To view the Multimedia News Release, please click:

multivu.prnewswire.com/mnr/prne/supergaygames/50518/ 
Inspired by the comic books, SuperGay has an original .... Original article &nbsp;: <a href="http://pr.gaeatimes.com/supergay-the-attack-of-his-ex-girlfriends-videogame-comes-out-available-for-apple-platforms-47250/">SuperGay &amp; the Attack of his Ex-Girlfriends Videogame Comes Out Available for Apple Platforms</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/supergay-the-attack-of-his-ex-girlfriends-videogame-comes-out-available-for-apple-platforms-47250/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Online Display Advertising Bounces Back</title>
		<link>http://pr.gaeatimes.com/online-display-advertising-bounces-back-46316/</link>
		<comments>http://pr.gaeatimes.com/online-display-advertising-bounces-back-46316/#comments</comments>
		<pubDate>Wed, 08 Jun 2011 05:00:00 +0000</pubDate>
		<dc:creator>Iab Europe</dc:creator>
		
		<category><![CDATA[Advertising]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Google]]></category>

		<category><![CDATA[Iab Europe]]></category>

		<category><![CDATA[June 8]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/online-display-advertising-bounces-back-46316/</guid>
		<description><![CDATA[BARCELONA, Spain, June 8, 2011  -

    - Double Digit Growth for Online Advertising as Display Drives European
Growth Rate to 15.3% Year-on-Year

    Display advertising is back! That&#39;s according to figures just released by
IAB Europe that show a revival in digital Display in 2010. With an average
growth rate of 21.3%, .... <a href="http://pr.gaeatimes.com/online-display-advertising-bounces-back-46316/">Read the original article &nbsp;: Online Display Advertising Bounces Back</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/online-display-advertising-bounces-back-46316/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Iroko Cardio International Chooses Veeva CRM for European-wide Deployment</title>
		<link>http://pr.gaeatimes.com/iroko-cardio-international-chooses-veeva-crm-for-european-wide-deployment-45387/</link>
		<comments>http://pr.gaeatimes.com/iroko-cardio-international-chooses-veeva-crm-for-european-wide-deployment-45387/#comments</comments>
		<pubDate>Thu, 19 May 2011 05:00:00 +0000</pubDate>
		<dc:creator>Veeva Systems</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[May 19]]></category>

		<category><![CDATA[Spain]]></category>

		<category><![CDATA[Veeva Systems]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/iroko-cardio-international-chooses-veeva-crm-for-european-wide-deployment-45387/</guid>
		<description><![CDATA[BARCELONA, May 19, 2011  - Iroko Cardio International (Geneva, Switzerland), a privately held
pharmaceutical company dedicated to reducing the incidence of major adverse
cardiac events (MACE), has adopted Veeva CRM to support all of its
representatives in nine European countries. Both field and office-based users
have begun to leverage the advanced functionality of the new system to manage
their .... <a href="http://pr.gaeatimes.com/iroko-cardio-international-chooses-veeva-crm-for-european-wide-deployment-45387/">Source &nbsp;: Iroko Cardio International Chooses Veeva CRM for European-wide Deployment</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/iroko-cardio-international-chooses-veeva-crm-for-european-wide-deployment-45387/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff</title>
		<link>http://pr.gaeatimes.com/grifols-and-talecris-biotherapeutics-announce-the-signing-of-a-consent-agreement-with-ftc-staff-44621/</link>
		<comments>http://pr.gaeatimes.com/grifols-and-talecris-biotherapeutics-announce-the-signing-of-a-consent-agreement-with-ftc-staff-44621/#comments</comments>
		<pubDate>Mon, 02 May 2011 05:00:00 +0000</pubDate>
		<dc:creator>Grifols S.a.</dc:creator>
		
		<category><![CDATA[Acquisitions / Mergers / Takeovers]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Grifols Sa]]></category>

		<category><![CDATA[Italy]]></category>

		<category><![CDATA[May 2]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/grifols-and-talecris-biotherapeutics-announce-the-signing-of-a-consent-agreement-with-ftc-staff-44621/</guid>
		<description><![CDATA[BARCELONA, Spain, May 2, 2011  - Grifols, S.A. (&#34;Grifols&#34;) and Talecris Biotherapeutics Holdings
Corporation (&#34;Talecris&#34;), announced today that they have signed a &#34;Consent
Agreement&#34; with the Staff of the Bureau of Competition of the US Federal
Trade Commission (FTC) by means of which the conditions for the merger
transaction between both companies are agreed. The Consent Agreement is
subject .... <a href="http://pr.gaeatimes.com/grifols-and-talecris-biotherapeutics-announce-the-signing-of-a-consent-agreement-with-ftc-staff-44621/" title="Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff">Source &nbsp;: Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/grifols-and-talecris-biotherapeutics-announce-the-signing-of-a-consent-agreement-with-ftc-staff-44621/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Advancell Announces the Initiation of a Clinical Phase IIb Study of ATH008 in Hand-foot Syndrome (or Palmar-plantar Erythrodysesthesia Syndrome)</title>
		<link>http://pr.gaeatimes.com/advancell-announces-the-initiation-of-a-clinical-phase-iib-study-of-ath008-in-hand-foot-syndrome-or-palmar-plantar-erythrodysesthesia-syndrome-44268/</link>
		<comments>http://pr.gaeatimes.com/advancell-announces-the-initiation-of-a-clinical-phase-iib-study-of-ath008-in-hand-foot-syndrome-or-palmar-plantar-erythrodysesthesia-syndrome-44268/#comments</comments>
		<pubDate>Wed, 20 Apr 2011 05:00:00 +0000</pubDate>
		<dc:creator>Advancell</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Advancell]]></category>

		<category><![CDATA[April 20]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/advancell-announces-the-initiation-of-a-clinical-phase-iib-study-of-ath008-in-hand-foot-syndrome-or-palmar-plantar-erythrodysesthesia-syndrome-44268/</guid>
		<description><![CDATA[Advancell has announced the initiation of a clinical phase IIb study of its treatment ATH008 for palmar-plantar erythrodysesthesia syndrome, or hand-foot syndrome, a painful side effect of chemotherapy. This treatment could be available on the market by the end of 2015 or beginning of 2016

BARCELONA, April 20, 2011  - ADVANCELL (www.advancell.net/), an
emerging Spanish biopharmaceutical ... <a href="http://pr.gaeatimes.com/advancell-announces-the-initiation-of-a-clinical-phase-iib-study-of-ath008-in-hand-foot-syndrome-or-palmar-plantar-erythrodysesthesia-syndrome-44268/" title="Advancell Announces the Initiation of a Clinical Phase IIb Study of ATH008 in Hand-foot Syndrome (or Palmar-plantar Erythrodysesthesia Syndrome)">Read more &raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/advancell-announces-the-initiation-of-a-clinical-phase-iib-study-of-ath008-in-hand-foot-syndrome-or-palmar-plantar-erythrodysesthesia-syndrome-44268/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols</title>
		<link>http://pr.gaeatimes.com/the-american-chamber-of-commerce-in-spain-awards-the-global-business-leader-award-2011-to-victor-grifols-roura-president-and-ceo-of-grifols-43705/</link>
		<comments>http://pr.gaeatimes.com/the-american-chamber-of-commerce-in-spain-awards-the-global-business-leader-award-2011-to-victor-grifols-roura-president-and-ceo-of-grifols-43705/#comments</comments>
		<pubDate>Wed, 06 Apr 2011 05:00:00 +0000</pubDate>
		<dc:creator>American Chamber Of Commerce In Spain</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Workforce Management / Human Resources]]></category>

		<category><![CDATA[American Chamber Of Commerce In Spain]]></category>

		<category><![CDATA[April 6]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/the-american-chamber-of-commerce-in-spain-awards-the-global-business-leader-award-2011-to-victor-grifols-roura-president-and-ceo-of-grifols-43705/</guid>
		<description><![CDATA[The award recognizes business people who foster responsible economic globalization

BARCELONA, Spain, April 6, 2011  - The American Chamber of Commerce in Spain (AmChamSpain) has chosen the
president and CEO of Grifols, Victor Grifols Roura, as the winner of its
Global Business Leader Award 2011. This award aims to recognize the
international efforts of business leaders, whether Spanish .... Source &nbsp;: <a href="http://pr.gaeatimes.com/the-american-chamber-of-commerce-in-spain-awards-the-global-business-leader-award-2011-to-victor-grifols-roura-president-and-ceo-of-grifols-43705/">The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/the-american-chamber-of-commerce-in-spain-awards-the-global-business-leader-award-2011-to-victor-grifols-roura-president-and-ceo-of-grifols-43705/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Estonia&apos;s Certification Authority, AS Sertifitseerimiskeskus, Adopts Safelayer&apos;s PKI Technology</title>
		<link>http://pr.gaeatimes.com/estonias-certification-authority-as-sertifitseerimiskeskus-adopts-safelayers-pki-technology-43710/</link>
		<comments>http://pr.gaeatimes.com/estonias-certification-authority-as-sertifitseerimiskeskus-adopts-safelayers-pki-technology-43710/#comments</comments>
		<pubDate>Wed, 06 Apr 2011 05:00:00 +0000</pubDate>
		<dc:creator>Safelayer</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[High Tech Security]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[April 6]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Safelayer]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/estonias-certification-authority-as-sertifitseerimiskeskus-adopts-safelayers-pki-technology-43710/</guid>
		<description><![CDATA[Safelayer Consolidated as a Supplier of eID and eSignature Solutions for Certification Services Providers (CSPs)

BARCELONA, Spain, April 6, 2011  - AS Sertifitseerimiskeskus, Estonia&#39;s principal certification
authority and provider of certificates for authentication and digital signing
for the Estonian eID card, has chosen to adopt Safelayer&#39;s technology for
implementing public key infrastructure (PKI) services. To modernize its
infrastructure, AS ... <a href="http://pr.gaeatimes.com/estonias-certification-authority-as-sertifitseerimiskeskus-adopts-safelayers-pki-technology-43710/">Original source on Gaea Times at  : Estonia&apos;s Certification Authority, AS Sertifitseerimiskeskus, Adopts Safelayer&apos;s PKI Technology</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/estonias-certification-authority-as-sertifitseerimiskeskus-adopts-safelayers-pki-technology-43710/feed/</wfw:commentRss>
		</item>
		<item>
		<title>HP Announces New Appointment for Carl Boustany</title>
		<link>http://pr.gaeatimes.com/hp-announces-new-appointment-for-carl-boustany-43347/</link>
		<comments>http://pr.gaeatimes.com/hp-announces-new-appointment-for-carl-boustany-43347/#comments</comments>
		<pubDate>Tue, 29 Mar 2011 05:00:00 +0000</pubDate>
		<dc:creator>Hp</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Personnel Announcements]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[Hp]]></category>

		<category><![CDATA[March 29]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/hp-announces-new-appointment-for-carl-boustany-43347/</guid>
		<description><![CDATA[BARCELONA, Spain, March 29, 2011  - HP announced that Carl Boustany has been appointed HP IHPS segment
specialist for Middle East, Mediterranean (Turkey and Greece) and Africa
(MEMA).

    Based in Dubai, Boustany will provide support for the IHPS team within
the MEMA region, promoting the HP T200 and the T300 Inkjet Web Presses.
Following the ... Read the original article on Gaea Times at  : <a href="http://pr.gaeatimes.com/hp-announces-new-appointment-for-carl-boustany-43347/">HP Announces New Appointment for Carl Boustany</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/hp-announces-new-appointment-for-carl-boustany-43347/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Sativex(R) Launched in Spain to Treat Spasticity in Multiple Sclerosis (MS)</title>
		<link>http://pr.gaeatimes.com/sativexr-launched-in-spain-to-treat-spasticity-in-multiple-sclerosis-ms-42636/</link>
		<comments>http://pr.gaeatimes.com/sativexr-launched-in-spain-to-treat-spasticity-in-multiple-sclerosis-ms-42636/#comments</comments>
		<pubDate>Mon, 14 Mar 2011 05:00:00 +0000</pubDate>
		<dc:creator>Almirall</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Almirall]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[March 14]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/sativexr-launched-in-spain-to-treat-spasticity-in-multiple-sclerosis-ms-42636/</guid>
		<description><![CDATA[Sativex(R) is Available From Today in Spain. The Approved Indication is Treatment of Spasticity due to MS in Patients not Responding to Other Therapies

BARCELONA, March 14, 2011  - Almirall, S.A. (ALM) announces that Sativex(R) is now
available to health professionals and patients in the Spanish hospital
pharmacies. It is the first specific treatment for spasticity in ... Original article on  : <a href="http://pr.gaeatimes.com/sativexr-launched-in-spain-to-treat-spasticity-in-multiple-sclerosis-ms-42636/">Sativex(R) Launched in Spain to Treat Spasticity in Multiple Sclerosis (MS)</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/sativexr-launched-in-spain-to-treat-spasticity-in-multiple-sclerosis-ms-42636/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Customize a Dream Vacation - Paradizo&apos;s Top Choices for Exclusive Luxury Tours</title>
		<link>http://pr.gaeatimes.com/customize-a-dream-vacation-paradizos-top-choices-for-exclusive-luxury-tours-42645/</link>
		<comments>http://pr.gaeatimes.com/customize-a-dream-vacation-paradizos-top-choices-for-exclusive-luxury-tours-42645/#comments</comments>
		<pubDate>Mon, 14 Mar 2011 05:00:00 +0000</pubDate>
		<dc:creator>Paradizo</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Hotels and Resorts]]></category>

		<category><![CDATA[Leisure]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[Travel]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[March 14]]></category>

		<category><![CDATA[Paradizo]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/customize-a-dream-vacation-paradizos-top-choices-for-exclusive-luxury-tours-42645/</guid>
		<description><![CDATA[BARCELONA, March 14, 2011  - You may have traveled here and there, but you&#39;ve never seen the world
through the eyes of an insider like the guides on these incredible luxury
vacations (paradizo.com/). Exclusive tour operators offer the
ultimate experience to spice up even the most ordinary vacation plans.

    To view the Multimedia News ... <a href="http://pr.gaeatimes.com/customize-a-dream-vacation-paradizos-top-choices-for-exclusive-luxury-tours-42645/" title="Customize a Dream Vacation - Paradizo&apos;s Top Choices for Exclusive Luxury Tours">Read more &raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/customize-a-dream-vacation-paradizos-top-choices-for-exclusive-luxury-tours-42645/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Disease Modifying Effect of Chondroitin Sulphate in Patients With Knee Osteoarthritis has Been Confirmed by MRI</title>
		<link>http://pr.gaeatimes.com/the-disease-modifying-effect-of-chondroitin-sulphate-in-patients-with-knee-osteoarthritis-has-been-confirmed-by-mri-42352/</link>
		<comments>http://pr.gaeatimes.com/the-disease-modifying-effect-of-chondroitin-sulphate-in-patients-with-knee-osteoarthritis-has-been-confirmed-by-mri-42352/#comments</comments>
		<pubDate>Mon, 07 Mar 2011 05:00:00 +0000</pubDate>
		<dc:creator>Prof. Jean-pierre Pelletier</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Barcelona]]></category>

		<category><![CDATA[March 7]]></category>

		<category><![CDATA[Prof. Jean-pierre Pelletier]]></category>

		<category><![CDATA[Spain]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/the-disease-modifying-effect-of-chondroitin-sulphate-in-patients-with-knee-osteoarthritis-has-been-confirmed-by-mri-42352/</guid>
		<description><![CDATA[A Clinical Trial by Prof. Jean-Pierre Pelletier has Been Published in Annals of the Rheumatic Diseases (1)

BARCELONA, March 7, 2011  - A group of Canadian researchers led by Prof. Jean-Pierre
Pelletier, Head of the Osteoarthritis Research Unit, at the University of
Montreal Hospital Research Centre, published a clinical trial, in which they
confirm, for the first time .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/the-disease-modifying-effect-of-chondroitin-sulphate-in-patients-with-knee-osteoarthritis-has-been-confirmed-by-mri-42352/">The Disease Modifying Effect of Chondroitin Sulphate in Patients With Knee Osteoarthritis has Been Confirmed by MRI</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/the-disease-modifying-effect-of-chondroitin-sulphate-in-patients-with-knee-osteoarthritis-has-been-confirmed-by-mri-42352/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

